Generic Name ORPHENADRINE/ASPIRIN/CAFFEINE Review Date Began Thu, 02/02/2023 - 12:00 Review Date Completed Tue, 03/14/2023 - 12:00 Conclusion PDL Product Committee Month Sat, 07/01/2023 - 12:00